To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy

J Nucl Med. 2021 Nov;62(11):1487-1488. doi: 10.2967/jnumed.121.263035. Epub 2021 Aug 26.

Authors

Sandy Srinivas¹, Andrei Iagaru²

Affiliations

¹ Division of Medical Oncology, Department of Medicine, Stanford University, Stanford, California; and.
² Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California aiagaru@stanford.edu.

No abstract available

MeSH terms

Antigens, Surface / metabolism
Glutamate Carboxypeptidase II* / metabolism
Humans
Ligands
Male
Prostatic Neoplasms / diagnostic imaging
Prostatic Neoplasms / metabolism
Prostatic Neoplasms / radiotherapy
Radiopharmaceuticals / therapeutic use

Substances

Glutamate Carboxypeptidase II
FOLH1 protein, human
Ligands
Antigens, Surface
Radiopharmaceuticals